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ABSTRACT
Jumonji domain-containing protein 6 (JMJD6) is a nu-
clear protein involved in histone modification, tran-
scription and RNA processing. Although JMJD6 is
crucial for tissue development, the link between its
molecular functions and its roles in any given differ-
entiation process is unknown. We report that JMJD6
is required for adipogenic gene expression and dif-
ferentiation in a manner independent of Jumonji C
domain catalytic activity. JMJD6 knockdown led to
a reduction of C/EBP and C/EBP protein expres-
sion without affecting mRNA levels in the early phase
of differentiation. However, ectopic expression of
C/EBP and C/EBP did not rescue differentiation.
Further analysis demonstrated that JMJD6 was as-
sociated with the Pparγ 2 and Cebpα loci and puta-
tive enhancers. JMJD6 was previously found asso-
ciated with bromodomain and extra-terminal domain
(BET) proteins, which can be targeted by the bro-
modomain inhibitor JQ1. JQ1 treatment prevented
chromatin binding of JMJD6, Pparγ 2 and Cebpα
expression, and adipogenic differentiation, yet had
no effect on C/EBP and C/EBP expression or
chromatin binding. These results indicate dual roles
for JMJD6 in promoting adipogenic gene expres-
sion program by post-transcriptional regulation of
C/EBP and C/EBP and direct transcriptional ac-
tivation of Pparγ 2 and Cebpα during adipocyte dif-
ferentiation.
INTRODUCTION
Jumonji C (JmjC) domain-containing proteins belong to
the family of ferrous iron (Fe2+)- and 2-oxoglutarate (2-
OG)-dependent dioxygenases that hydroxylate a broad
range of substrates that includes proteins and nucleic acids
(1,2). A number of JmjC domain-containing proteins act as
epigenetic regulators involved in development as well as in
diseases such as cancer, inflammation, metabolic and neu-
rological disorders (3,4). Among the family of JmjC domain
proteins, Jumonji domain containing protein 6 (JMJD6)
is an evolutionarily conserved nuclear protein widely ex-
pressed in various tissues (5,6). Although knockout mice
showed developmental delay and abnormalities in multiple
tissues, the mechanism by which JMJD6 regulates tissue de-
velopment has not been demonstrated (6–9).
JMJD6 regulates gene expression at different levels. It
has been shown that JMJD6 alters covalent modifications
on histones as well as on transcription factors and splic-
ing proteins via its lysine hydroxylase or methyl-arginine
demethylase activity (10–14), though the functional conse-
quences of JMJD6-mediated modification of these proteins
is not fully characterized. JMJD6 also controls the release
of paused RNA polymerase II through its interaction with
bromodomain containing 4 (BRD4) protein at distal reg-
ulatory elements (15). In addition, biochemical characteri-
zation of JMJD6 showed its capacity to bind RNA in vitro
(16). Other evidence indicates that JMJD6 not only inter-
acts with splicing factors but also associates with nascent
RNAs derived from a reporter and from endogenous genes,
and that the interaction modulates constitutive and alter-
native splicing (17,18). However, whether these regulatory
functions in gene expression account for the roles of JMJD6
in tissue development has not yet been determined.
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Adipocyte differentiation is a critical aspect of organ-
ismal development and plays a major role in adipose tis-
sue homeostasis (19–22). An increase in adipocyte number
(hyperplasia) has been linked to excess nutrient overload
and obesity (23,24). On the contrary, impaired adipocyte
differentiation is associated with lipodystrophy and sys-
temic metabolic disorders such as insulin resistance, dys-
lipidemia and steatosis (25–27). The molecular events con-
trolling adipocyte differentiation have been extensively
studied in tissue culture systems and in animal mod-
els over the past 20 years. The integration of multiple
signaling pathways leads to the activation of early adi-
pogenic regulators including CCAAT/enhancer-binding
protein (Cebpβ) andCCAAT/enhancer-binding protein 
(Cebpδ), followed by the activation of the master regulators,
peroxisome proliferator-activated receptor- (Pparγ ) and
CCAAT/enhancer-binding protein  (Cebpα) (28). PPAR
andC/EBP in turn promote the expression of a large set of
phenotypic genes in mature adipocytes (29,30). Recent ad-
vances in genome-wide analysis for DNase I hypersensitive
sites (DHS) and the binding of transcription factors and co-
factors have provided significant insights into the epigenetic
control of gene expression during adipogenic differentiation
(31–33).
In the present study, we investigated the roles of JMJD6
in gene expression regulation by using a well-characterized
adipocyte differentiation model. The results showed that
JMJD6 is essential for initiation of the transcriptional
program that promotes the terminal differentiation of
C3H10T1/2 mouse mesenchymal cells. The adipogenic
function of JMJD6 is independent of its JmjC domain ac-
tivity. Moreover, knockdown of JMDJ6 caused a deficiency
in C/EBP and C/EBP protein expression without an ef-
fect on the mRNA levels, indicating a post-transcriptional
regulatory function on C/EBP and C/EBP expression.
Further analysis identified the binding of JMJD6 at the
Pparγ 2 and Cebpα genomic loci and nearby putative en-
hancers when Pparγ 2 and Cebpα are expressed. Targeting
the chromatin readers for JMJD6 with the bromodomain
and extra-terminal domain (BET) protein inhibitor, JQ1,
displaced JMJD6 from the loci and prevented gene expres-
sion, indicating a role for JMJD6 and BET proteins in reg-
ulating Pparγ 2 and Cebpα gene transcription. Overall, our
results indicate distinct functions of JMJD6 in facilitating
adipogenic gene expression program via transcriptional and
post-transcriptional mechanisms.
MATERIALS AND METHODS
Tissue culture
Mouse C3H10T1/2, 293T and BOSC23 cells were main-
tained in growth media consisting of Dulbecco’s modified
Eagle’s medium (DMEM) high glucose medium (Invitro-
gen), 10% fetal calf serum (FCS, Sigma) and 100 U/ml
penicillin/streptomycin (Invitrogen). For adipogenic induc-
tion, confluent cells were cultured in DMEM high glucose
medium supplementedwith 10%FCS, 10g/ml insulin, 0.5
mM IBMX, 1 Mdexamethasome and 5 MTroglitazone
(all reagents from Sigma) for 48 h. After induction, the dif-
ferentiating cells were maintained in DMEM high glucose
medium supplemented with 10% FCS and 5 g/ml insulin.
Media was changed every other day until harvest.
Plasmid DNA construction
pENTR/pTER+ vector and pLentiX2 DEST vector were
gifts from Dr. Eric Campeau. The preparation of small
hairpin RNA (shRNA) lentiviral constructs was performed
as previously described (34). Briefly, JMJD6 shRNAs,
GFP shRNA and scrambled sequence shRNA oligonu-
cleotides were individually cloned into pENTR/pTER+
vector. The pENTR/pTER+ shRNA constructs were sub-
sequently incubated with LR clonase II enzyme mix (Invit-
rogen) and pLentiX2 DEST vector containing a puromycin
resistance gene to generate pLentiX2 DEST/shJmjd6,
pLentiX2 DEST/shGFP and pLentiX2 DEST/shCtrl con-
structs. The sequences of shRNAoligonucleotides are listed
in Supplementary Table S1. To generate the constructs
for JMJD6 and HIF1AN protein expression, the cod-
ing sequence of JMJD6 and HIF1AN with a C-terminal
FLAG tag sequence was amplified from mouse embry-
onic fibroblast cDNA by reverse transcriptase-polymerase
chain reaction (RT-PCR) and cloned into pBABE retro-
viral vector containing a blasticidin resistance gene (35)
and pcDNA3.1(-) vector (Invitrogen). The construct for the
catalytic-inactive mutant JMJD6 (H187A/D189A) protein
(14) was generated from the wild type JMJD6 construct by
QuikChange Lightning site-directed mutagenesis kit (Agi-
lent). The primers for cloning and mutagenesis are listed in
Supplementary Table S1.
Virus preparation and transduction
Lentivirus preparation was performed as previously de-
scribed (34). Briefly, the shRNA lentiviral constructs were
co-transfected with pLP1, pLP2 and pVSVG packaging
vectors into 293T cells with Lipofectamine 2000 reagent
(Invitrogen). The constructs encoding wild type JMJD6
(JMJD6-wt) and the catalytic-inactive mutant JMJD6
(JMJD6-mut) were individually transfected into BOSC23
cells (36). The viral supernatant was harvested after 48 h
incubation and filtered through 0.45 m syringe filter (Mil-
lipore). To infect C3H10T1/2 cells, 2 ml of the filtered su-
pernatant supplementedwith 4g/ml of polybrene (Sigma)
were used to infect one million cells for 48 h. The infected
cells were then selected in media containing 2.5 g/ml
puromycin (Invitrogen) or 5 g/ml of blasticidin (Invitro-
gen).
Oil Red O staining
Cells were washed once with PBS and fixed in 10%
phosphate-buffered formalin (Fisher Scientific) overnight
at room temperature. The next day, the cells were washed
with 60% isopropanol and air dried completely. The cells
were stained with 60% Oil-Red O (AMRESCO) for 10 min
and washed extensively with running tap water. To quantify
staining, Oil Red O was extracted with 100% isopropanol
and measured at optical density 500 nm (OD500).
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Gene expression analysis
Total RNA was isolated using TRIzol reagent (Invitrogen)
and treatedwithDNaseI (Invitrogen) according to theman-
ufacturer’s instructions. cDNAswere prepared from 1g of
total RNA with random hexamers (Roche) and the Super-
script III reverse transcriptase kit (Invitrogen). Real-time
quantitative PCR was performed on a StepOne Plus real-
time PCR machine with Fast SYBR green master mix (Ap-
plied Biosystems). The relative gene expression levels were
calculated as 2∧(Ct5S rRNA – Ctgene) and were normalized to
the experimental control as indicated (37). The primers are
listed in Supplementary Table S2.
Western blot analysis
Cells were washed twice with cold PBS and harvested in
RIPA buffer (50 mM Tris-HCl, pH7.4, 150 mM NaCl, 1
mM EDTA, 1% NP-40 and 0.25% sodium deoxycholate)
supplemented with protease inhibitor cocktail (Roche).
Mouse adipose tissue extracts were prepared as described
(38). Protein concentration was measured using Bio-Rad
protein assay. The samples were mixed with 4X sodium
dodecyl sulphate (SDS) loading buffer (240 mM Tris-
HCl, pH6.8, 8% SDS, 40% glycerol, 0.01% bromophenol
blue and 10% -mercaptoethanol) and boiled at 95◦C for
10 min. Samples were separated on 10% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto PVDF membrane (Bio-Rad). The
blots were blocked in 3% non-fat milk overnight at 4◦C.
After a sequential incubation with the primary antibod-
ies and HRP-conjugated secondary antibodies, the blots
were developed on X-ray films with ECL western blot-
ting detection reagents (GE Healthcare Life Sciences). Pri-
mary antibodies against JMJD6 (sc-11366), JMJD6 (sc-
28348), HIF1AN (sc-26219), PPAR (sc-7273), C/EBP
(sc-61), C/EBP (sc-150), C/EBP (sc-151) and -ACTIN
(sc-81178) were purchased from Santa Cruz Biotechnology.
PI3-kinase p85 (ABS233) antibody was purchased from
Millipore. The phospho-C/EBP (#3084) antibody was
purchased from Cell Signaling. The anti-FLAG rabbit anti-
serawas described (39). The anti-BRD2 (A302–583A), anti-
BRD3(A302–367A) and anti-BRD4 (A301–985A50) anti-
bodies were purchased from Bethyl Laboratories. The sec-
ondary antibodies (NA9340 and NA9310) were purchased
from GE Healthcare Life Sciences. ImageJ software was
used for image quantification.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as previ-
ous described (40). Briefly, cells were fixed in 1% formalde-
hyde at room temperature for 10 min and harvested as cell
pellets. The cell pellets were re-suspended in cell lysis buffer
(50 mM Tris-HCl, pH 8.0, 1% SDS, 10 mM EDTA, pH
8.0 and protease inhibitors) and sonicated in a Bioruptor
(UCD-200, Diagenode) to obtain fragmented DNA sized
around 500 bp. The samples were centrifuged at 12 000 x g
for 10 min at 4◦C to remove insoluble debris. The super-
natant containing the chromatin was pre-cleared with 40
l of a 50% slurry protein A beads (Protein A Sepharose
CL-4B, GE Healthcare Life Sciences) supplemented with
0.2 mg/ml salmon sperm DNA (Invitrogen) and 0.5 mg/ml
BSA (Invitrogen). 50 g of DNAwere immunoprecipitated
with 4 g of specific antibody or 20 l of serum overnight
at 4◦C. The next day, the immunocomplexes were incubated
with 60 l of a 50% slurry of protein A beads for 1 h at
4◦C. After extensively washing, the immunocomplexes were
eluted in 1% SDS and 1% NaHCO3. The eluted samples
were subjected to reverse cross-linking for 4 h at 65◦C. The
immunoprecipitated DNA fragments were purified using
the QIAquick PCR purification kit (QIAGEN) and used as
templates for quantitative PCR. The fold difference of im-
munoprecipitated DNA fraction relative to input was cal-
culated as 2∧(Ctinput – CtChIP) (41). The primers are listed
in Supplementary Table S3. The antibodies for ChIP as-
says are C/EBP (sc-150), C/EBP (sc-151), RNA poly-
merase II (sc-899) and rabbit IgG control (sc-2027) from
SantaCruzBiotechnology. The anti-BRD4 (A301–985A50)
antibody was from Bethyl Laboratories. The anti-JMJD6
rabbit sera was made against a bacterial expressed GST-
fusion with human JMJD6 (aa 2–414), which was cloned by
PCR-amplification and subsequently inserted into pGEX-
2T plasmid. The primers for cloning are listed in Supple-
mentary Table S1. The specificity of the JMJD6 antisera
was evaluated by western blot as shown in Supplementary
Figure S1.
Immunoprecipitation
Cells were washed twice with cold PBS and lysed with a
buffer containing 50 mM Tris-HCl, pH7.4, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate and protease in-
hibitor cocktail (Roche) on ice for 30 min. The cell lysate
were pre-cleared by 40l of a 50% slurry of proteinA beads.
1 mg of the cell lysate was incubated with either 20 l of
anti-JMJD6 rabbit antisera or rabbit IgG control (sc-2027)
for 2 h at 4◦C. The samples were then incubated with 60
l of a 50% slurry of protein A beads for 1 h at 4◦C. The
immunocomplexes were eluted by adding 2X SDS loading
buffer and subsequently boiled at 95◦C for 10 min before
SDS-PAGE and subsequent western blotting.
Small interfering RNA knockdown
ON-TARGETplus mouse Cebpβ and Cepbδ siRNA
SMART pools and the non-targeting control siRNA pool
were purchased from Dharmacon GE Healthcare Life
Sciences. The target sequences for Cepbβ mRNA were
GAGCGACGAGUACAAGAUG, CCUUUAGACC-
CAUGGAAGU, GCACCCUGCGGAACUUGUU and
GAAAAGAGGCGUAUGUAUA. The target sequences
forCepbδ mRNAwere CGCGGAAGGAACACGGGAA,
AGUUGUCGGCCGAGAACGA, GUAAGGAGAUG-
GACGCGUU and GGCACUGGACUGCGAGAGA.
Briefly, cells were plated at a density of 1.5 × 105 cells per
well in 12 well plates overnight and then transfected with
siRNA pools using Lipofectamine 2000 in Opti-MEM
medium (Invitrogen). After 4 h incubation, the medium
was replaced with the normal growth medium for 20 h
prior to adipogenic induction.
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Plasmid and In vitro synthesized RNA transfection
pcDNA3-EGFP (#13031), pcDNA3.1(-) mouse C/EBP
LAP (#12557) and pcDNA3.1(-) mouse C/EBP (#12559)
were obtained from Addgene. For the preparation of in
vitro synthesizedRNA, pcDNA3.1(-) mouse C/EBP LAP,
pcDNA3.1(-) mouse C/EBP and pcDNA3-EGFP plas-
mids were linearized with XbaI or HindIII and were in
vitro transcribed with mMESSAGE mMACHINE T7 Ul-
tra Transcription Kit (Ambion) according to the manufac-
turer’s instructions. The capped and polyadenylated RNAs
were further purified with RNA Clean and Concentrator
Kit (Zymo Research). For transfection, 1.5 × 105 cells were
plated in each well of 12-well plates overnight and trans-
fectedwith either 2g of the plasmids or in vitro synthesized
RNAs using Lipofectamine 2000 in Opti-MEM medium.
After 4 h incubation, the media was replaced with the nor-
mal growth medium for 20 h prior to adipogenic induction.
Statistical analysis
At least three independent experiments were performed as
indicated in the Figure legends. The values are presented
as the mean ± SEM. Statistical analyses were performed
using Student’s t-test with two-tailed distribution and equal
variance.
RESULTS
JMJD6 is expressed in adult adipose tissues and during the
differentiation of C3H10T1/2 cells
To understand the biological roles of JMJD6 in adipocyte
differentiation, we first examined the expression of JMJD6
in adult adipose tissues and in differentiating adipocytes.
Western blot analysis showed that JMJD6 protein is ex-
pressed in both white and brown adipose tissues from 6-
week-old male and female C57BL/6 mice (Figure 1A).
For differentiating adipocytes, we used mouse multipotent
mesenchymal C3H10T1/2 cells as a tissue culture model
(42). C3H10T1/2 cells differentiate into adipocytes upon
stimulation with an adipogenic induction media contain-
ing insulin, dexamethasone, 3-isobutyl-1-methylxanthine
and Troglitazone. Induction of the master adipogenic reg-
ulators, PPAR and C/EBP, occurred on day 1 post-
induction (Figure 1B). JMJD6 is present in differentiating
C3H10T1/2 adipocytes even before the onset of the differ-
entiation (Figure 1B). A transient increase of JMJD6 pro-
tein and mRNA expression was observed in the differen-
tiating cells as compared to the levels at day 0 when the
cells were undifferentiated (Figure 1C, D). Previous work
has shown that JMJD6 proteins form oligomers (43–46).
Consistent with western blot analysis and quantification of
the monomer species (Figure 1B, C), examination of a time
course of differentiating cells indicated that the oligomeric
form was present at the onset of differentiation and its level
increased by days 2–3 post-differentiation and decreased
thereafter (Supplementary Figure S2). Based on these re-
sults, we concluded that JMJD6 is present in adult adipose
tissues and expressed throughout the course of differentia-
tion of C3H10T1/2 cells.
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Figure 1. JMJD6 is expressed in adult adipose tissues and in differentiating
C3H10T1/2 adipocytes. (A) Representative western blots for JMJD6 and
-ACTIN protein levels in adipose tissues from 6-week-old male and fe-
male C57BL/6 mice. igWAT: inguinal white adipose tissue; pgWAT: perig-
onadal white adipose tissue; iBAT: interscapular brown adipose tissue.
(B) Representative western blots for JMJD6, C/EBP and PPAR pro-
tein levels in undifferentiated (day 0) and in differentiating (day 1 to 6)
C3H10T1/2 cells. PI3K levels were probed as a loading control. (C)Quan-
tification of JMJD6 protein levels from three independent western blots.
The levels of JMJD6 were normalized to PI3K loading control and are
presented as the relative expression levels to the day 0 sample (SEM, n =
3, *P < 0.05; **P < 0.01). (D)Jmjd6 mRNA levels in the differentiating
C3H10T1/2 cells were determined by real-time qPCR. The mRNA levels
were normalized to 5s rRNA levels and the sample at day 0 was set as 1
(SEM, n = 3, *P < 0.05; **P < 0.01).
Knocking down JMJD6 impaired adipogenic differentiation
of C3H10T1/2 cells
To investigate the function of JMJD6 in adipocyte differ-
entiation, we knocked down JMJD6 in C3H10T1/2 cells
by introduction of small hairpin RNAs prior to the onset
of differentiation. Two shRNAs specific for JMJD6 were
used. shJ6–2 targets the 5′ UTR and the start of the 5′ cod-
ing sequence, whereas sh6–3 targets the 3′ UTR of Jmjd6
mRNA. The cells were induced to differentiate upon con-
fluence. Adipogenic differentiation was evaluated at day 6
post-induction by quantifying the intracellular lipid con-
tent. Two distinct control shRNAs, a scramble sequence
called shCtrl, and shGFP, had no effect on the adipogenic
differentiation (Figure 2A, B; Supplementary Figure S3). A
significant reduction in lipid accumulation in the JMJD6
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Figure 2. JMJD6 is required for the terminal differentiation of C3H10T1/2 cells independent of JmjC domain activity. (A) Representative Oil-Red O
staining images of day 6 post-induced C3H10T1/2 cells. Endogenous JMJD6 was knocked down by either of two shRNAs (shJ6–2 or shJ6–3). A scramble
shRNA construct (shCtrl) was used a control. (B)Quantification of Oil Red O staining. The values are presented as the average of optical density at 500 nm
(OD500) from three independent experiments (SEM, n = 3, **P < 0.01). (C) Representative western blots for JMJD6, C/EBP and PPAR protein levels
in the day 6 post-induced cells as indicated. PI3K levels were probed as a loading control. (D) The mRNA levels of adipocyte-associated genes in the day 6
post-differentiated cells. The individual mRNA levels were normalized to 5s rRNA levels. The normalized expression levels of the control cells were set as
1 (SEM, n = 3, *P < 0.05; **P < 0.01). (E) Representative western blots of the ectopically expressed wild type JMJD6 (JMJD6-wt) and catalytic-inactive
mutant JMJD6 (JMJD6-mut) in C3H10T1/2 cells prior to differentiation. The blots were probed with either anti-FLAG antiserum or a JMJD6-specific
antibody. (F) Representative Oil Red O staining images of day 6 post-differentiated cells as indicated. The C3H10T1/2 cells expressing either wild type
JMJD6 (JMJD6-wt) or catalytic-inactive mutant (JMJD6-mut) or empty vector were subsequently transduced with lentiviral constructs containing either
a scramble shRNA control (shCtrl) or a shRNA targeting the 3′ UTR of Jmjd6 mRNA (shJ6–3). (G) Representative western blots for JMJD6, C/EBP
and PPAR protein levels in day 6 post-induced cells as indicated.
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knockdown cells compared to the scramble shRNA con-
trol cells was observed (Figure 2A, B), demonstrating that
JMJD6 knockdown reduced the adipogenic potential of
C3H10T1/2 cells. Moreover, the levels of the master reg-
ulators for terminal differentiation PPAR and C/EBP
were significantly reduced in the day 6 post-induced JMJD6
knockdown cells (Figure 2C). Consistent with the reduc-
tion in protein levels, Pparγ and Cebpα mRNA expres-
sion was significantly reduced in the JMJD6 knockdown
cells (Figure 2D). Other adipocyte-associated genes such
as sterol regulatory element-binding transcription factor-1c
(Srebp1c), fatty acid synthase (Fasn), adiponectin (AdipoQ)
and fatty acid binding protein 4 (Fabp4) were also down-
regulated (Figure 2D). These results indicated that the
knockdown of JMJD6 led to a failure of differentiation of
C3H10T1/2 cells due to the inability of the cells to activate
the adipogenic gene expression program.
JMJD6 regulates adipogenesis independently of JmjC do-
main catalytic activity
To determine whether the catalytic activity of the JmjC
domain in JMJD6 is required for adipocyte differentia-
tion, we used a catalytically inactive mutant JMJD6 that
includes substitution of histidine 187 and aspartate 189
with alanine (14). C3H10T1/2 cells were first transduced
with the retroviral constructs encoding FLAG-tagged wild
type JMJD6 (JMJD6-wt) or catalytically inactive mutant
JMJD6 (JMJD6-mut) or with the empty vector. Ectopi-
cally expressed JMJD6 protein was evaluated by western
blot analysis with an antiserum recognizing FLAG epitope
and an antibody specific for JMJD6 (Figure 2E). Consis-
tent with the literature indicating that JMJD6 oligomeriza-
tion requires JmjC domain catalytic activity (45), the wild
type JMJD6 protein oligomerized, but the over-expressed
mutant JMJD6 was only present as a monomer (Fig-
ure 2E). The cells were subsequently transduced with the
lentiviral vector containing shRNA to deplete endoge-
nous JMJD6 protein. Upon adipogenic induction, a sig-
nificant percentage of cells expressing FLAG-tagged wild
type JMJD6 with endogenous JMJD6 depletion (JMJD6-
wt/shJ6–3) differentiated into adipocytes (Figure 2F). In-
terestingly, the cells expressing the catalytically inactive
mutant JMJD6 (JMJD6-mut/shJ6–3) differentiated into
adipocytes to the same extent as the cells expressing wild
type JMJD6 (JMJD6-wt/shJ6–3) (Figure 2F). Moreover,
the protein levels of the reintroduced wild type and mu-
tant JMJD6 proteins were similar to levels of endogenous
JMJD6 in the control cells (Figure 2G, lane 4 and lane 6
compared to lane 1). The expression levels of PPAR and
C/EBP protein were comparable in the wild type and in
the mutant JMJD6 cells (Figure 2G, lane 4 and 6). These re-
sults suggest that the catalytic activity of the JmjC domain
in the JMJD6 protein is dispensable for the adipogenic dif-
ferentiation of C3H10T1/2 cells.
Down-regulation of C/EBP andC/EBP is associated with
the differentiation deficiency in the JMJD6 knockdown cells
To determine the causes of the differentiation defect in the
JMJD6 knockdown cells, we analyzed the activation of
Pparγ andCebpα genes, which is crucial for terminal differ-
entiation. C/EBP and C/EBP are early adipogenic reg-
ulators that collaborate to activate Pparγ and Cebpα tran-
scription during the early stage of differentiation (28,47).
By examining the expression of C/EBP and C/EBP,
we found that JMJD6 knockdown resulted in a reduction
of C/EBP and C/EBP protein expression at 3 h post-
induction (Figure 3A). However, we did not observe any
effect of JMJD6 knockdown on Cebpβ and Cebpδ mRNA
levels (Figure 3B), which suggests that JMJD6 is involved in
the post-transcriptional control of C/EBP and C/EBP
expression. Both Cebp and Cebpδ are intronless genes.
Therefore, the known function of JMJD6 in RNA splicing
would not be a direct mechanism that caused the reduction
C/EBP and C/EBP protein expression.We examined the
protein stability of C/EBP and C/EBP by cycloheximide
treatment and western blot analysis. Protein samples were
collected for up to 5 h in the presence of cycloheximide. No
significant difference was detected in the degradation rate of
C/EBP or C/EBP between the JMJD6 knockdown cells
and the control cells (Supplementary Figure S4). Therefore,
JMJD6 knockdown had no effect on C/EBP and C/EBP
stability.
Since JMJD6 knockdown did not completely abolish
C/EBP and C/EBP expression, we examined whether
suboptimal levels of C/EBP and C/EBP were suffi-
cient to cause the differentiation deficiency. C3H10T1/2
cells were pre-treated with the siRNA targeting Cebpβ
and Cebpδ mRNA 24 h prior to adipogenic induction.
C/EBP and C/EBP protein levels were examined in 3
h post-induced cells (Figure 3C, D). At a concentration
of 50 nM, the siRNA treatment caused only a modest de-
crease in C/EBP and C/EBP protein levels. However,
the adipogenic differentiation of C3H10T1/2 was signifi-
cantly blocked (Figure 3E, F). These results support the
conclusion that the decease in C/EBP and C/EBP pro-
tein expression contributes to the differentiation deficiency
in JMJD6 knockdown cells.
Reduced C/EBP protein levels correlated with the decrease
of RNA Polymerase II recruitment at the Pparγ 2 andCebpα
gene loci
Aprevious study suggested that C/EBP functions as a pio-
neer transcription factor for the activation of the transcrip-
tional program during the early stages of adipocyte differ-
entiation (31). Since phosphorylation of C/EBP modu-
lates its transcriptional activity (48), we further examined
the effect of JMJD6 knockdown on the levels of C/EBP
and phosphorylated C/EBP at threonine 188 in the differ-
entiating cells. We found that JMJD6 knockdown reduced
C/EBP levels throughout the first 48 h of differentiation
(Figure 4A), which is consistent with the previous results
(Figure 3A). Moreover, the level of C/EBP phosphoryla-
tion was directly proportional to the level of total C/EBP
both in shCtrl and shJ6–3 cells (Figure 4A and Supplemen-
tary Figure S5), indicating that JMJD6 was not specifically
affecting C/EBP phosphorylation. We therefore explored
the possibility that reducedC/EBP protein levelsmight di-
rectly contribute to the activation of the Pparγ 2 andCebpα
genes by analyzing its binding to the corresponding pro-
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Figure 3. Down-regulation of C/EBP and C/EBPwas associated with the differentiation deficiency in the JMJD6 knockdown cells. (A) Representative
western blots for C/EBP and C/EBP protein levels in the 3 h post-induced control cells (shCtrl) and the JMJD6 knockdown cells (shJ6–2 and shJ6–3).
PI3K levels were probed as a loading control. LAP and LIP represent different isoforms of C/EBP (B)Cebpβ and Cebpδ mRNA levels in the 3 h post-
induced cells. The normalized expression levels of the control cells were set as 1. The values are presented as the average of relative expression levels with
standard error (SEM, n = 3, ns: not significant). (C, D) Representative western blots for C/EBP and C/EBP protein levels in 3 h post-induced cells that
were pre-treated with the indicated siRNAs for 24 h prior to adipogenic induction. -ACTIN levels were probed as a loading control. (E) Representative
Oil Red O staining images of day 6 post-induced C3H10T1/2 cells with siRNA treatment as indicated. (F)Quantification of Oil Red O staining. The values
are presented as the average of optical density at 500 nm (OD500) from three independent experiments (SEM, n = 3, *P < 0.05, **P < 0.01).
moter regions. As expected, ChIP assays showed that the
binding of C/EBP was reduced at the Pparγ 2 and Cebpα
proximal promoters in the JMJD6 knockdown cells upon
adipogenic induction (Figure 4B, C), which correlates with
the inhibition of Pparγ 2 and Cebpα expression. It has been
shown that JMJD6 directly contributes toRNApolymerase
II transcription through binding to distal enhancers (15).
We therefore examined the binding of JMJD6 and RNA
polymerase II at the Pparγ 2 and Cebpα loci and their pu-
tative enhancers. For calling the putative enhancers, we
searched published data sets for genomic regions that were
enriched with DNAse I hypersensitivity (DHS), MED1,
p300, and BRG1 binding, and H3K4me1/2 and H3K27Ac
incorporation but with low levels of H3K4me3 incorpora-
tion (Supplementary Figure S6) (32,49). The −9.5 kb, +96
kb, and +100 kb regions of the Pparγ 2 locus and +37 kb
regions of the Cepbα were previously called as putative en-
hancers in immortalized brown preadipocytes (49). ChIP-
qPCR results showed that the binding of JMJD6 increased
upon differentiation across the Pparγ 2 andCebpα genomic
loci (Supplementary Figure S7A, B). In addition, the bind-
ing of JMJD6 and RNA polymerase II at most of the se-
quences examined was decreased in the JMJD6 knockdown
cells (Figure 4D–G). These data suggest that the failure of
Pparγ 2 and Cebpα gene activation caused by the JMJD6
knockdown is likely a consequence of the reduced binding
of C/EBP, JMJD6 and RNA polymerase II at these ge-
nomic loci.
Ectopic expression of C/EBP and C/EBP is not sufficient
to restore adipogenic differentiation in the JMJD6 knock-
down cells
To determine whether the JMJD6-dependent defects in
Pparγ 2 and Cebpα gene activation were entirely related
to the decrease in C/EBP and C/EBP protein lev-
els, we attempted to rescue the adipogenic differentiation
in the JMJD6 knockdown cells by ectopically expressing
C/EBP and C/EBP. Transient transfection of the plas-
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Figure 4. Reduced C/EBP protein levels correlated with the decrease in RNA polymerase II occupancy at the Pparγ 2 and Cebpα loci and putative
enhancers. (A) Representative western blots for the levels of C/EBP and phosphorylated C/EBP at threonine 188 in the control cells (shCtrl) and in
the JMJD6 knockdown cells (shJ6–3) throughout the early phase of differentiation. PI3K levels were probed as a loading control. (B) ChIP of C/EBP at
the Pparγ 2 and Cebpα proximal promoters. (C) ChIP of rabbit IgG for negative control. (D, E) ChIP of JMJD6 and (F, G) ChIP of RNA polymerase II
at the Pparγ 2 and Cebpα loci and nearby putative enhancers. The values are presented as the average% input from at least three independent experiments
(SEM, n≥3, *P < 0.05, **P < 0.01).
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Figure 5. Ectopic expression of C/EBP and C/EBPwas not sufficient to rescue the differentiation deficiency caused by JMJD6 knockdown. (A)Repre-
sentative western blots for the levels of C/EBP, C/EBP and JMJD6 protein expression in the control cells (shCtrl) and in the JMJD6 knockdown cells
(shJ6–2 and shJ6–3) 24 h after transfection with the plasmids encoding C/EBP(LAP) and C/EBP protein. An empty vector was used as a transfection
control. (B) C/EBP, C/EBP and JMJD6 protein expression in the cells 24 h after transfection with in vitro synthesized Cebpβ and Cebpδ mRNA. In
vitro synthesized EGFP mRNA was used as a transfection control. (C) Representative Oil Red O staining images of the day 6 post-induced cells as indi-
cated. (D)Pparγ 2 and Cebpα mRNA levels in the day 6 post-induced cells that were transfected with EGFPmRNA or a combination of Cebpβ and Cebpδ
mRNA (Cebpβ+δ) as indicated. The values are presented as the average of relative expression levels with standard error (SEM, n = 3, *P < 0.05; **P <
0.01, ns: not significant).
mids encoding C/EBP (LAP isoform) and C/EBP pro-
tein into the scramble control cells resulted in robust ex-
pression of C/EBP and C/EBP (Figure 5A). However,
the JMJD6 knockdown cells failed to express these pro-
teins (Figure 5A), even though the plasmid-derived mR-
NAs were present in the JMJD6 knockdown cells (Sup-
plementary Figure S8A, B). These data suggest that the
post-transcriptional mechanism by which JMJD6 regulates
endogenous C/EBP and C/EBP also regulates the ec-
topic expression of these proteins. To bypass the post-
transcriptional defects resulting from the knockdown of
JMJD6, we introducedCebpβ andCebpδmRNAs that were
synthesized in vitro (Supplementary Figure S8C, D). This
procedure generated equivalent protein expression both in
the JMJD6 knockdown cells and in the control cells (Fig-
ure 5B). We then sought to determine whether the intro-
duction of Cebpβ and Cebpδ mRNA could rescue the dif-
ferentiation deficiency resulting from JMJD6 knockdown.
For the mRNA transfection control, we chose in vitro tran-
scribed EGFP mRNA because of the length similarity to
Cebpβ and Cebpδ mRNA and the minimal effect of EGFP
on the transcriptional program. As shown by Oil Red O
staining, ectopic expression ofCebpβ and/orCebpδmRNA
was not sufficient to rescue the differentiation deficiency
(Figure 5C). The JMJD6 knockdown cells transfected with
a combination of Cebpβ and Cebpδ mRNA failed to ex-
press endogenous Pparγ 2 and Cebpα mRNA to the levels
observed in the control cells (Figure 5D). Based on these
results, we conclude that the JMJD6 knockdown cells must
have multiple defects in Pparγ 2 and Cepbα gene activa-
tion. Since JMJD6 was present at the Pparγ 2 and Cepbα
genomic loci (Figure 4D, E), we speculated that JMJD6
might directly contribute to the transcriptional activation
of Pparγ 2 and Cepbα.
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Figure 6. Targeting the chromatin reader for JMJD6 impaired adipogenic differentiation. (A) Representative Oil Red O staining images of day 6 post-
induced C3H10T1/2 cells treated with JQ1 or DMSO. The treatment was performed in the first 48 h during the adipogenic induction. (B) Quantification
of Oil Red O staining. The values are presented as the average of optical density at 500 nm (OD500) from three independent experiments (SEM, n = 3,
*P < 0.05, **P < 0.01). (C) Representative western blots for the indicated proteins in the 3 h and 24 h post-induced cells in the presence of 1 M JQ1 or
DMSO as a vehicle control. (D) The mRNA levels of the indicated genes in the 3 h and 24 h post-induced cells in the presence of 1 M JQ1 or DMSO.
The values are presented as the average of relative expression levels from three independent experiments with standard error (SEM, n = 3, *P < 0.05; **P
< 0.01, ns: not significant).
Targeting the chromatin reader for JMJD6 blocked the adi-
pogenic transcriptional program
JMJD6 has no characterized DNA binding domain (50)
and also lacks DNA binding ability in vitro (16). Studies
have shown that JMJD6 physically interacts with the chro-
matin reader proteins BRD4 and BRD2 (15,51). To deter-
mine the mechanisms by which JMJD6 binds to the ge-
nomic loci and directly controls Pparγ 2 and Cepbα gene
activation, we targeted the chromatin reader for JMJD6
by the BET protein-specific inhibitor JQ1 (52). We found
that JQ1 treatment significantly inhibited adipogenic dif-
ferentiation at a 1 M dose (Figure 6A, B). By analyzing
the expression of adipogenic regulators, we found that JQ1
treatment blocked PPAR and C/EBP protein expression
(Figure 6C). Unlike in the JMJD6 knockdown cells, JQ1
had no effect on C/EBP and C/EBP levels at either 3
or 24 h post-induction (Figure 6C). Consistent with the
protein analysis, JQ1 treatment inhibited the expression of
Pparγ 2 and Cebpα mRNAs without or with minimal ef-
fect on Cebpβ and Cebpδ mRNA expression, respectively
(Figure 6D). The data indicate that the inhibition of adi-
pogenic differentiation by JQ1 occurs via a mechanism that
affects PPAR2 and C/EBP expression without affecting
expression of the C/EBP and C/EBP. Though JQ1 af-
fects neither the expression of JMJD6 (Figure 6C) nor the
interaction of JMJD6 with BRD4 (Supplementary Figure
S9), ChIP experiments showed that JQ1 treatment reduced
the binding of JMJD6, BRD4 and RNA polymerase II at
the Pparγ 2 and Cepbα loci and their putative enhancers
(Figure 7A–F), thereby providing a mechanism for the in-
hibition of Pparγ 2 and Cebpα gene expression. JQ1 treat-
ment did not affect the binding of C/EBP and C/EBP at
the Pparγ 2 and Cebpα promoter regions (Figure 7G, H).
These results indicate that BRD4-mediated JMJD6 chro-
matin binding at the Pparγ 2 and Cepbα genomic loci con-
tributes to gene activation during differentiation.
Collectively, the data support the conclusion that JMDJ6
acts as both a post-transcriptional and a transcriptional
regulator during adipogenesis. A schematic diagram sum-
marizing our findings is presented in Figure 8.
DISCUSSION
JMJD6 has multiple mechanisms of action
The effect of JMJD6 knockdown on C/EBP and C/EBP
expression suggests a novel role of JMJD6 in the post-
translational control of gene expression. We had deter-
mined that JMJD6 knockdown had no effect on C/EBP
and C/EBP protein stability, and since both Cebpβ and
Cebpδ are intronless genes, the reduction of C/EBP and
C/EBP expression cannot be due to a defect in splic-
ing of these two transcripts. Moreover, the general trans-
lation machinery is unlikely affected, because the in vitro
synthesized Cebpβ and Cebpδ mRNA can be translated
in the JMJD6 knockdown cells. Therefore, we concluded
that JMJD6 promotes C/EBP and C/EBP expression
at one or more steps between RNA synthesis and trans-
lation. The known JMJD6 interacting proteins are mostly
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Figure 7. JQ1 treatment perturbed the binding of JMJD6 and RNA polymerase II at the Pparγ 2 and Cebpα loci and putative enhancers. (A, B) ChIP of
JMJD6, (C, D) ChIP of BRD4, and (E, F) ChIP of RNA polymerase II at the Pparγ 2 and Cebpα loci and nearby putative enhancers in 24 h post-induced
C3H10T1/2 cells in the presence of 1M JQ1 or DMSO. (G) ChIP of C/EBP and (H) ChIP of C/EBP at the Pparγ 2 and Cebpα proximal promoters
in 24 h post-induced C3H10T1/2 cells. The values are presented as the average% input from four independent experiments (SEM, n= 4, *P< 0.05, **P<
0.01, ns: not significant). For negative control, ChIP of rabbit IgG was performed under the same conditions. The average % input from rabbit IgG ChIPs
was below 0.05% in all cases (data not shown).
involved in RNA processing (14). In addition, structural
and biochemical characterization of JMJD6 also suggests
a broad RNA binding capability (16). Perhaps JMJD6 is
a part of Cebpβ and Cebpδ messenger ribonucleoprotein
particles (mRNPs) and is involved in the assembly, process-
ing, remodeling and localization of these mRNPs. Alter-
natively, JMJD6 might facilitate mRNA binding to ribo-
somes, which would be supported by the known interaction
with ribosomal proteins and translation initiation factors
(14,46). Taken together, we propose that JMJD6 plays mul-
tiple roles in post-transcriptional regulation of gene expres-
sion, regulating splicing on intron containing genes and as
well as a second function related to other aspects of RNA
processing. To get insight on how JMJD6 is involved in the
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Figure 8. Schematic diagram of the dual functions of JMJD6 in the control of adipogenic regulator expression. (A) JMJD6 participates in the post-
transcriptional regulation of C/EBP andC/EBPand transcriptional activation ofPpaγ 2 andCebpα genes. (B)Upon JMJD6knockdown, dual functions
of JMJD6 are compromised, and that results in a reduction of C/EBP and C/EBP protein levels and the mRNA levels from the Ppaγ 2 andCebpα genes.
(C) Treatment of JQ1 blocks the transcriptional activation function of JMJD6 without an effect on C/EBP and C/EBP protein levels.
various steps of mRNA metabolism in the context of adi-
pogenesis, it would be interesting to identify and charac-
terize the interacting protein partners as well as the asso-
ciated RNA species with unbiased approaches such as im-
munoprecipitation followed by mass spectrometry or deep
sequencing.
Though our studies demonstrated that JMJD6 depen-
dent regulation of C/EBP and C/EBP expression con-
tributes to the activation of the lineage determinants
Pparγ 2 and Cebpα, the work also indicates that this func-
tion is not sufficient to drive Pparγ 2 and Cebpα expression
and adipogenic differentiation. Thus there are additional
roles for JMJD6 in promoting adipogenesis. Our ChIP re-
sults showed that JQ1 treatment caused the loss of JMJD6
binding at the Pparγ 2 and Cebpα loci in a manner inde-
pendent of controlling C/EBP and C/EBP expression.
Therefore, JMJD6 likely directly contributes to the tran-
scriptional activation of Pparγ 2 and Cebpα genes, perhaps
in cooperation with the known JMJD6 interacting protein,
BRD4. Consistent with this hypothesis, treatment of cells
with JQ1 caused a decrease in BRD4 and RNA polymerase
II occupancy at the examined loci. Though previous work
by others connected JMJD6 to the release of RNA poly-
merase II pausing (15), it appears that in the context of
Pparγ 2 and Cebpα activation, JMJD6 may also promote
RNA polymerase II recruitment.
The decrease of RNA polymerase II binding at the pu-
tative enhancers near the Pparγ 2 and Cebpα loci indicates
that both JMJD6 knockdown and JQ1 treatment might not
only inhibit the transcription of Pparγ 2 and Cebpα genes
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but also the enhancer-derived RNAs (eRNAs). Noncoding
eRNA transcripts have been identified in a number of cell
types including adipocytes (53,54). Although the function
of eRNAs are not fully understood, several lines of evidence
suggest the roles of eRNA in promoting enhancer-promoter
chromatin looping (55) and RNA polymerase II recruit-
ment at promoters and gene bodies (56,57). Therefore the
contributions of JMJD6 to transcription might occur via at
both promoter and enhancer sequences.
Studies examining the effects of JQ1 onRNApolymerase
II transcription have indicated that JQ1 selectively binds to
the BRD4 bromodomain, and prevents the genomic bind-
ing by BRD4 and its associated factors, pTEFb and Medi-
ator (58,59). Our study indicates that JMJD6 is one of the
BRD4-associated proteins in the differentiating cells (Sup-
plementary Figure S9), and the binding of JMJD6 at the ge-
nomic loci is prevented by JQ1 (Figure 7). However, the in-
hibitory effects of JQ1 on the adipogenic transcription pro-
gram might be pleiotrophic, because BRD4 interacts with
multiple transcription factors and chromatin regulators in
addition to acetylated histones through its bromodomain
(60). Furthermore, it is important to note that JQ1 has high
affinity for the bromodomains of BRD2, BRD3, BRD4
and BRDT (52). Except for testes/oocyte-specific BRDT,
BRD2, BRD3, BRD4 might all contribute the gene tran-
scription program during adipogenic differentiation, pos-
sibly because these BET proteins facilitate transcriptional
elongation through acetylated nucleosomes (61,62). Fur-
ther complicating matters, BRD2 shows anti-adipogenic
function in a hypomorphic mouse model as well as in 3T3-
L1 preadipocytes (63,64). It is still unclear how BRD2 re-
presses Pparγ 2 gene expression, but the evidence indicated
that BRD2 associates with PPAR and represses the abil-
ity of PPAR to activate downstream target genes (63).
There may therefore be a regulatory balance between posi-
tive and negatively acting BET proteins. Although we did
not identify any interaction of JMJD6 with BRD2 and
BRD3 at the time point we assayed in the differentiat-
ing cells by co-immunoprecipitation (Supplementary Fig-
ure S9), since JMJD6 potentially interacts with both BRD2
and BRD4 (15,51), it is possible that JMJD6 collaborates
with these distinct chromatin readers in a temporal-and
spatial-dependent manner that differentially regulates the
adipogenic transcriptional program.
JMJD6 function during adipogenesis is independent of the
JmjC domain activity
JMJD6 was originally identified as an arginine demethylase
(10) but subsequent work from different groups has been
contradictory; some studies support the original findings
while others do not and suggest that JMJD6 instead acts as
a lysine hydroxylase (12–15,45,65). Our study demonstrated
that the adipogenic function of JMJD6 is independent of
JmjC domain activity. A recent study also reported a JmjC
domain independent function of JMJD6 in the splicing of
a reporter gene (17). Thus while JMJD6 has the poten-
tial to post-translationally modify chromatin and/or pro-
teins involved in transcription, splicing, or any other cellu-
lar process, any such activity is not required for adipogenic
differentiation, or, at best, contributes to the process in a
non-essential manner. Given the diverse roles described for
JMJD6, perhaps it functions as a scaffold protein that fa-
cilitates the localization and functions of other regulatory
proteins.
The idea of JMJD6 function that is independent of JmjC
domain catalytic activity raises the question of what JMJD6
domains mediate its functions. In addition to the JmjC do-
main, JMJD6 has a polyserine domain, multiple nuclear
localization sequences, a nuclear export sequences, an AT-
hook DNA binding motif, and a sumoylation site (50,66).
To date, only the polyserine domain and nuclear localiza-
tion sequences have been functionally evaluated (5,46,66).
We attempted to identify regions of JMJD6 that are neces-
sary for adipogenic differentiation by ectopically expressing
a series of truncated JMJD6 proteins in C3H10T1/2 cells.
However, the expression levels of these truncated JMJD6
proteins were either very low or not detectable (Supple-
mentary Figure S10). These findings are consistent with
the work of others who have also reported that trunca-
tions and deletions in JMJD6 decrease protein stability
or form protein aggregates when they are ectopically ex-
pressed (44). Therefore, the domain(s) of JMJD6 neces-
sary for the adipogenic function is still unclear. A system-
atic structure-function study using point mutations or small
deletions would be necessary to identify the JmjC domain-
independent functions of JMJD6.
SUMMARY
In conclusion, our work demonstrated that JMJD6 has
multiple roles in promoting adipogenic differentiation via
post-transcriptional regulation of C/EBP and C/EBP
regulatory proteins and direct transcriptional regulation of
the genes encoding the PPAR2 and C/EBP regulatory
proteins (Figure 8). JMJD6 is therefore a critical regulator
of the lineage determining transcription factors that control
adipogenic differentiation.
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